Intravenous (IV) solutions are supplemental fluids comprising sugar, electrolytes, water, and medications. It is given to patients as per their medical condition, requirements, body size, and age to treat electrolyte balance and restore fluid volume. IV therapy is widely in use.

The IV, intravenous solutions market in 2021 reached US $13.2 billion value, and the anticipation is to reach 2027 at US$18.6billion, thereby revealing a 5.96% CAGR in the period between 2022-2027. The uncertainties of COVID19 and the insights are into consideration.

Intravenous Solutions' current scope

The coronavirus, COVID-19 outbreak was sudden and the demand for IV solutions was high worldwide. It was necessary as it provides to the patients in the ICU essential nutrients. The increasing number of people having cancer, diabetes gastrointestinal disorder, and neurological diseases represent the growth factors. Faster response time is associated with higher efficacy and IV solution therapy contributes to the growth of the IV market. 

COVID-19 overcomes chronic dehydration causing memory problems, fatigue, medical conditions, and irritability. With the individuals increasing participation in physical activities the IV solutions adoption is increasing aiming for fast recovery. It is used to treat hangovers and migraines and to improve skin conditions.  

The leading IV manufacturers are launching portable product variants that are easy to use at home as drips. These environmental rising concerns are premixed solutions, and they reduce the packaging waste amount. Investments are rising by health agencies for numerous countries in the healthcare sector to create a suitable market outlook.

Future forecast of the industry

The intravenous solution injections are receiving approvals from regulatory authorities. It is to drive the market growth for the global IV solutions. New intravenous solution injection launches are for various diseases treatment such as gastrointestinal diseases, and dehydration, and are expected to drive the market growth as it is in use for transfusion, infusion, and clinical nutrition.

The market will witness substantial growth in the IV market owing to various factors such as high chronic disease prevalence and many geriatric populations across the globe. 


Why Intravenous solutions are experiencing driving demand?

The diseases prevalence such as gastrointestinal diseases, diabetes, and neurological diseases are due to unhealthy lifestyle. They are the main factors promoting the intravenous solutions demand. 

A survey report by CDC shows in 2020 in the U.S nearly 34.2 million people have diabetes and it is around 10.5 of the U.S population. It leads to malnourishment and some provide nutrition. Moreover, increasing concentration on the healthcare sector is sure to drive the intravenous solutions sales. New product innovations by the manufacturers offer better convenience and reduce packaging driving the intravenous solutions market growth.

Regional Insights

The global intravenous solution market categorizes into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.  In the global intravenous solution market, Europe holds a dominant position. It increases intravenous nutrition products and solutions in the market. For instance, Baxter International Inc launched in Europe NUMETA G13E in 300 ml. It is an intravenous ready-to-use parenteral nutrition for preterm infants below the gestation age of 37 weeks.

The Asia Pacific is also seeing rapid growth in the demand for the intravenous solution market. It is due to increasing launches of advanced intravenous technology and solutions by key players. For instance, Eurolife Healthcare launched two intravenous IV products: Discport and Lifeport in the market. The product has smart intravenous infusion, encompassing the latest technology, thereby reducing the infection chances.

Innovating Research Methodologies and Models

There is no limit to a specific market or one approach to obtain the exact analyzing data. There is an ever-evolving process report meeting the demands and customer needs. It supports data science methods broadly and combines business acumen. 

The research data about consumers and customers show we can go to lengths to obtain them. There is the next-gen automation tools integration with human judgment to ascertain relevant and recent insights, qualitative and quantitative, and to package them in digestible chunks.

Justifying the Shortages' impact

IV solutions, the techniques to conserve fluids, such as conversion to oral therapy from IV, and nonessential infusions must be discontinued as an integrated clinical practice. There should be medication handling to support improved utilization. There is a need to empower pharmacists so that they come up with techniques to maximize the supply. It can be extending the use dates of the product or some other way to justify the impact of shortages.

Supply Stability

The manufacturing capacity development will help meet the health care system's needs. Manufacturers cannot keep changing their capital, significant labor, and regulatory requirements. To ensure proper utilization it is necessary to introduce transparency and pragmatism to the industry and economies. It will ensure consistent use and overall supply in the market. It helps minimize the future production shortfalls impact on the market.


The growth and opportunities if IV Fluid

The pharmaceutical industry, as a whole, is booming. With the COVID-19 pandemic reflecting the poor state of public health of many countries, change is imperative.

Three main factors why the requirement for IV fluids will not drop any soon are:
Increase of gastrointestinal diseases
Gallstones, constipation, and other digestion-related diseases are on a rapid rise. The fast-paced modern culture, coupled with the degrading quality of food intake is the major reason.

Presence of large-scale malnutrition
Malnutrition is a significant issue. The increase in elderly and pediatric malnutrition is an unfortunate reason for the high-demand for IV fluids.

IV fluids assist in abnormal fluid handling — a profound case of malnutrition.

Inevitability during certain operations and medical treatments
IV fluids are a must during the conduct of specific operations. Medical conditions like dialysis, chronic diarrhoea require a constant supply of IV fluids. 

The rise in chronic diseases is acting as a catalyst to the expansion of the IV fluids industry. With an expected CAGR of 6.1%, the growth potential of this industry is immense.